Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

Antitumor nucleosides disclosed by Yamasa Shoyu

May 3, 1996

GBC590 progresses to toxicity testing

April 26, 1996

Taisho isolates FD-594 from Streptoverticillium

April 26, 1996

Repligen terminates rPF4 development agreement

April 26, 1996

Antiandrogen research at Roussel Uclaf

April 26, 1996

Topotecan approval recommended

April 26, 1996

MitoExtra enters clinical trials

April 26, 1996

Glaxo Wellcome/BioChem Pharma antitumor agent described at 211th ACS

April 19, 1996

Photofrin approved for marketing in France

April 19, 1996

NU-1064 and NU-1076, PARP inhibitors

April 19, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 7, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 6, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Science in 2025: the best of the rest
BioWorld Science
A review of 2025's noteworthy advances in medical research, including GLP-1 receptor agonists as anti-aging drugs, tumor-agnostic therapies and xenotransplants.
Development and characterization of anti-CD19 in vivo CAR T therapy
BioWorld Science
Shenzhen Grit Biotechnology Co. Ltd. and Shanghai Vitalgen Biopharma Co. Ltd. recently presented their work to develop and evaluate a novel anti-CD19 in vivo CAR...